# Biodistribution and Pathophysiology Study of 11C-para-aminobenzoic Acid

> **NCT05611905** · — · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 13 (actual)

## Conditions studied

- Renal Excretion
- Bacterial Infections
- Inflammatory Disease
- Oncologic Disease

## Interventions

- **COMBINATION_PRODUCT:** 11C-para-aminobenzoic acid PET/CT
- **DRUG:** Probenecid

## Key facts

- **NCT ID:** NCT05611905
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-22
- **Primary completion:** 2025-11-08
- **Final completion:** 2025-11-08
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2025-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05611905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05611905, "Biodistribution and Pathophysiology Study of 11C-para-aminobenzoic Acid". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05611905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*